Bajaj Healthcare (BHL) Stock Skyrockets with India Regulators Authorizing Generic Ivermectin for COVID-19 Indication

Bajaj Healthcare (BHL) Stock Skyrockets with India Regulators Authorizing Generic Ivermectin for COVID-19 Indication

Bajaj Healthcare (BHL) stock rose 6.32% with the authorization by India’s drug regulator to produce and commercialize lvejaj, a branded version of the generic antiparasitic drug ivermectin approved for treating COVID-19 on May 6, 2021. Ivermectin was authorized in India because with over 50 clinical trials and observational studies showing positive results as well as widespread usage in the country to manage the pandemic, the authorities were ready to acknowledge the reality that the product is helping mitigate even more damages from the pandemic. The drug initially discovered in Japan is used widely around the world despite recalcitrant resistance to a holistic acknowledgement of the evidence from Western research institutes, regulators, and even the World Health Organization (WHO). Bajaj Healthcare isn’t the first of commercial pharmaceutical companies to move into the space as a company in France (MedinCell) as well as firm from Bulgaria (HuvePharma) also produce versions of the drug targeting COVID-19. Several countries have authorized the use of ivermectin targeting COVID-19, such as in Eastern Europe, South America, Africa, and Asia. TrialSite has been the leading media plat...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee